Literature DB >> 28636705

Inflammation in the Neurocircuitry of Obsessive-Compulsive Disorder.

Sophia Attwells1, Elaine Setiawan2, Alan A Wilson3, Pablo M Rusjan2, Romina Mizrahi4, Laura Miler2, Cynthia Xu2, Margaret Anne Richter5, Alan Kahn3, Stephen J Kish4, Sylvain Houle3, Lakshmi Ravindran6, Jeffrey H Meyer4.   

Abstract

Importance: For a small percentage of obsessive-compulsive disorder (OCD) cases exhibiting additional neuropsychiatric symptoms, it was proposed that neuroinflammation occurs in the basal ganglia as an autoimmune response to infections. However, it is possible that elevated neuroinflammation, inducible by a diverse range of mechanisms, is important throughout the cortico-striato-thalamo-cortical circuit of OCD. Identifying brain inflammation is possible with the recent advance in positron emission tomography (PET) radioligands that bind to the translocator protein (TSPO). Translocator protein density increases when microglia are activated during neuroinflammation and the TSPO distribution volume (VT) is an index of TSPO density. Objective: To determine whether TSPO VT is elevated in the dorsal caudate, orbitofrontal cortex, thalamus, ventral striatum, dorsal putamen, and anterior cingulate cortex in OCD. Design, Setting, and Participants: This case-control study was conducted at a tertiary care psychiatric hospital from May 1, 2010, to November 30, 2016. Participants with OCD (n = 20) and age-matched healthy control individuals (n = 20) underwent a fluorine F 18-labeled N-(2-(2-fluoroethoxy)benzyl)-N-(4-phenoxypyridin-3-yl)acetamide PET scan. It is a high-quality second-generation TSPO-binding PET radiotracer. All participants were drug and medication free, nonsmoking, and otherwise healthy. Main Outcomes and Measures: The TSPO VT was measured in the dorsal caudate, orbitofrontal cortex, thalamus, ventral striatum, dorsal putamen, and anterior cingulate cortex. Compulsions were assessed with the Yale-Brown Obsessive Compulsive Scale.
Results: In the OCD and healthy groups, the mean (SD) ages were 27.4 (7.1) years and 27.6 (6.6) years, respectively, and 11 (55%) and 8 (40%) were women, respectively. In OCD, TSPO VT was significantly elevated in these brain regions (mean, 32%; range, 31%-36% except anterior cingulate cortex, 24%; analysis of variance, effect of diagnosis: P < .001 to P = .004). Slightly lower elevations in TSPO VT (22%-29%) were present in other gray matter regions. The Yale-Brown Obsessive Compulsive Scale measure of distress associated with preventing compulsive behaviors significantly correlated with TSPO VT in the orbitofrontal cortex (uncorrected Pearson correlation r = 0.62; P = .005). Conclusions and Relevance: To our knowledge, this is the first study demonstrating inflammation within the neurocircuitry of OCD. The regional distribution of elevated TSPO VT argues that the autoimmune/neuroinflammatory theories of OCD should extend beyond the basal ganglia to include the cortico-striato-thalamo-cortical circuit. Immunomodulatory therapies should be investigated in adult OCD, rather than solely childhood OCD, particularly in cases with prominent distress when preventing compulsions.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28636705      PMCID: PMC5710556          DOI: 10.1001/jamapsychiatry.2017.1567

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  52 in total

1.  An automated method for the extraction of regional data from PET images.

Authors:  Pablo Rusjan; David Mamo; Nathalie Ginovart; Douglas Hussey; Irina Vitcu; Fumihiko Yasuno; Suhara Tetsuya; Sylvain Houle; Shitij Kapur
Journal:  Psychiatry Res       Date:  2006-06-21       Impact factor: 3.222

Review 2.  Gilles de la Tourette syndrome.

Authors:  Mary M Robertson; Valsamma Eapen; Harvey S Singer; Davide Martino; Jeremiah M Scharf; Peristera Paschou; Veit Roessner; Douglas W Woods; Marwan Hariz; Carol A Mathews; Rudi Črnčec; James F Leckman
Journal:  Nat Rev Dis Primers       Date:  2017-02-02       Impact factor: 52.329

3.  Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging.

Authors:  Sonia Lavisse; Martine Guillermier; Anne-Sophie Hérard; Fanny Petit; Marion Delahaye; Nadja Van Camp; Lucile Ben Haim; Vincent Lebon; Philippe Remy; Frédéric Dollé; Thierry Delzescaux; Gilles Bonvento; Philippe Hantraye; Carole Escartin
Journal:  J Neurosci       Date:  2012-08-08       Impact factor: 6.167

4.  Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study.

Authors:  Ryohei Matsumoto; Masanori Ichise; Hiroshi Ito; Tomomichi Ando; Hidehiko Takahashi; Yoko Ikoma; Jun Kosaka; Ryosuke Arakawa; Yota Fujimura; Miho Ota; Akihiro Takano; Kenji Fukui; Kazuhiko Nakayama; Tetsuya Suhara
Journal:  Neuroimage       Date:  2009-08-04       Impact factor: 6.556

5.  Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.

Authors:  Miran Kenk; Thiviya Selvanathan; Naren Rao; Ivonne Suridjan; Pablo Rusjan; Gary Remington; Jeffrey H Meyer; Alan A Wilson; Sylvain Houle; Romina Mizrahi
Journal:  Schizophr Bull       Date:  2014-11-09       Impact factor: 9.306

Review 6.  Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders.

Authors:  Rainer Rupprecht; Vassilios Papadopoulos; Gerhard Rammes; Thomas C Baghai; Jinjiang Fan; Nagaraju Akula; Ghislaine Groyer; David Adams; Michael Schumacher
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

Review 7.  Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder.

Authors:  S Saxena; A L Brody; J M Schwartz; L R Baxter
Journal:  Br J Psychiatry Suppl       Date:  1998

8.  Systemic inflammation induces anxiety disorder through CXCL12/CXCR4 pathway.

Authors:  L Yang; M Wang; Y Y Guo; T Sun; Y J Li; Q Yang; K Zhang; S B Liu; M G Zhao; Y M Wu
Journal:  Brain Behav Immun       Date:  2016-03-04       Impact factor: 7.217

9.  Increased binding of peripheral benzodiazepine receptor in Alzheimer's disease measured by positron emission tomography with [11C]DAA1106.

Authors:  Fumihiko Yasuno; Miho Ota; Jun Kosaka; Hiroshi Ito; Makoto Higuchi; Talant K Doronbekov; Shoko Nozaki; Yota Fujimura; Michihiko Koeda; Takashi Asada; Tetsuya Suhara
Journal:  Biol Psychiatry       Date:  2008-06-02       Impact factor: 13.382

Review 10.  Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD).

Authors:  G M Soomro; D Altman; S Rajagopal; M Oakley-Browne
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
View more
  47 in total

1.  Concentration, distribution, and influence of aging on the 18 kDa translocator protein in human brain: Implications for brain imaging studies.

Authors:  Junchao Tong; Belinda Williams; Pablo M Rusjan; Romina Mizrahi; Jean-Jacques Lacapère; Tina McCluskey; Yoshiaki Furukawa; Mark Guttman; Lee-Cyn Ang; Isabelle Boileau; Jeffrey H Meyer; Stephen J Kish
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-20       Impact factor: 6.200

Review 2.  Obsessive-Compulsive Disorder: Autoimmunity and Neuroinflammation.

Authors:  Mona Gerentes; Antoine Pelissolo; Krishnamoorthy Rajagopal; Ryad Tamouza; Nora Hamdani
Journal:  Curr Psychiatry Rep       Date:  2019-08-01       Impact factor: 5.285

3.  Immunoglobulin A Dysgammaglobulinemia Is Associated with Pediatric-Onset Obsessive-Compulsive Disorder.

Authors:  Kyle Williams; Leah Shorser-Gentile; Suraj Sarvode Mothi; Noah Berman; Mark Pasternack; Daniel Geller; Jolan Walter
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-03-20       Impact factor: 2.576

4.  In Vivo Imaging of Translocator Protein in Long-term Cannabis Users.

Authors:  Tania Da Silva; Sina Hafizi; Jeremy J Watts; Cynthia Shannon Weickert; Jeffrey H Meyer; Sylvain Houle; Pablo Rusjan; Romina Mizrahi
Journal:  JAMA Psychiatry       Date:  2019-12-01       Impact factor: 21.596

Review 5.  Neuroinflammation in psychiatric disorders: PET imaging and promising new targets.

Authors:  Jeffrey H Meyer; Simon Cervenka; Min-Jeong Kim; William C Kreisl; Ioline D Henter; Robert B Innis
Journal:  Lancet Psychiatry       Date:  2020-10-21       Impact factor: 27.083

Review 6.  Cortico-basal ganglia circuits underlying dysfunctional control of motor behaviors in neuropsychiatric disorders.

Authors:  Ana Mafalda Vicente; Gabriela J Martins; Rui M Costa
Journal:  Curr Opin Genet Dev       Date:  2020-07-17       Impact factor: 5.578

7.  Immune Aberrations in Obsessive-Compulsive Disorder: a Systematic Review and Meta-analysis.

Authors:  Theodore D Cosco; Toby Pillinger; Hadeer Emam; Marco Solmi; Sanjay Budhdeo; A Matthew Prina; Michael Maes; Dan J Stein; Brendon Stubbs; Andre F Carvalho
Journal:  Mol Neurobiol       Date:  2018-10-31       Impact factor: 5.590

Review 8.  Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway.

Authors:  Alexandre Vallée; Yves Lecarpentier; Jean-Noël Vallée
Journal:  Mol Psychiatry       Date:  2021-04-09       Impact factor: 15.992

Review 9.  Applicability, potential and limitations of TSPO PET imaging as a clinical immunopsychiatry biomarker.

Authors:  Livia J De Picker; Benno C M Haarman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-18       Impact factor: 9.236

10.  Peripartum complications associated with obsessive compulsive disorder exacerbation during pregnancy.

Authors:  Calliope Holingue; Jack Samuels; Valeria Guglielmi; Wendy Ingram; Gerald Nestadt; Paul S Nestadt
Journal:  J Obsessive Compuls Relat Disord       Date:  2021-03-22       Impact factor: 1.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.